Cargando…
The Mectizan(® )Donation Program – highlights from 2005
Through the Mectizan(® )Donation Program, Merck & Co., Inc. has donated Mectizan (ivermectin, MSD) for the treatment of onchocerciasis worldwide since 1987. Mectizan has also been donated for the elimination of lymphatic filariasis (LF) since 1998 in African countries and in Yemen where onchocer...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618829/ https://www.ncbi.nlm.nih.gov/pubmed/17005039 http://dx.doi.org/10.1186/1475-2883-5-11 |